Haemato-Oncology

Haemato-Oncology: Advanced Blood Cancer Diagnosis and Treatment in India

Haemato-Oncology is a specialised branch of medicine that focuses on the diagnosis, treatment and long-term management of cancers affecting the blood, bone marrow and lymphatic system. These conditions, commonly known as blood cancers, include leukaemia, lymphoma, multiple myeloma and other malignant disorders involving blood-forming tissues.

A diagnosis of blood cancer can raise many questions for patients and their families. Understanding the exact type of cancer, its stage, available treatment options and expected care journey is an important part of making informed medical decisions. Haemato-oncologists, also known as blood cancer specialists, assess each patient's condition using clinical examinations, laboratory investigations, pathology findings and specialised diagnostic tests before recommending an appropriate treatment approach.

At Siris Healthcare, patients can explore information about blood cancer treatment in India, specialist consultations and hospitals offering oncology and haematology services. Our platform helps patients and families understand available healthcare options and connect with relevant medical professionals for further guidance.

What Conditions Does Haemato-Oncology Treat?

Haemato-oncology primarily deals with malignant conditions that develop in blood cells, bone marrow and the lymphatic system. These cancers can affect the production and normal functioning of red blood cells, white blood cells, platelets and other components of the immune system.

The type of blood cancer, its biological characteristics, disease progression and the patient's overall health determine the appropriate treatment plan.

1. Leukaemia

Leukaemia is a type of blood cancer that begins in the bone marrow, where blood cells are produced. It generally involves the abnormal growth of white blood cells or their precursor cells, which can interfere with normal blood cell production.

Common types include:

• Acute lymphoblastic leukaemia (ALL)
• Acute myeloid leukaemia (AML)
• Chronic lymphocytic leukaemia (CLL)
• Chronic myeloid leukaemia (CML)

Symptoms may include persistent fatigue, frequent infections, unexplained fever, easy bruising, unusual bleeding and anaemia. However, symptoms vary between individuals, and these signs can also occur in conditions unrelated to cancer.

Treatment may involve chemotherapy, targeted medicines, immunotherapy, selected cellular therapies or stem cell transplantation, depending on the specific leukaemia subtype and clinical findings.

2. Lymphoma

Lymphoma is a cancer that develops in the lymphatic system, an important part of the body's immune defence network. It commonly affects lymphocytes, which are white blood cells responsible for helping the body fight infections.

The two major categories are:

• Hodgkin lymphoma: A type of lymphoma characterised by specific abnormal cells identified during pathological examination.
• Non-Hodgkin lymphoma: A diverse group of lymphatic cancers with different subtypes, growth patterns and treatment requirements.

Common symptoms may include painless swelling of lymph nodes in the neck, armpits or groin, unexplained fever, night sweats, persistent fatigue and unintended weight loss.

Depending on the lymphoma subtype and disease stage, treatment may include chemotherapy, immunotherapy, targeted therapy, radiation therapy or stem cell transplantation in selected cases.

3. Multiple Myeloma

Multiple myeloma is a blood cancer that develops from plasma cells, a type of white blood cell found in the bone marrow. Abnormal plasma cells multiply and may interfere with healthy blood cell production, bone health and kidney function.

Some commonly associated features include:

• Persistent bone pain, particularly in the back or ribs.
• Recurrent infections.
• Anaemia and ongoing fatigue.
• Elevated calcium levels.
• Kidney-related complications.
• Bone weakness or fractures.

Treatment options may include targeted medicines, immunotherapy, corticosteroids, chemotherapy and autologous stem cell transplantation for suitable patients. Treatment selection depends on disease characteristics, organ function, age and overall fitness.

4. Myelodysplastic Syndromes and Other Bone Marrow Cancers

Myelodysplastic syndromes (MDS) are a group of disorders in which the bone marrow produces abnormal or insufficient numbers of healthy blood cells. Some forms can progress to acute myeloid leukaemia.

Other malignant and pre-malignant bone marrow conditions may also require specialist evaluation, detailed blood investigations and long-term monitoring.

Management depends on the specific diagnosis and may include supportive treatment, medicines, blood transfusions or stem cell transplantation in selected patients.

Common Symptoms of Blood Cancer

The symptoms of blood cancer are not always obvious during the early stages. Some patients discover an abnormality during routine blood testing, while others seek medical attention because of persistent or unexplained symptoms.

Possible warning signs include:

• Persistent tiredness, weakness or unexplained anaemia.
• Frequent or recurring infections.
• Unexplained fever or night sweats.
• Unintentional weight loss.
• Swollen lymph nodes.
• Unusual bruising or bleeding.
• Persistent bone or joint pain.
• Abdominal discomfort or a feeling of fullness.
• Pale skin or breathlessness associated with anaemia.

These symptoms do not automatically indicate blood cancer. They can occur in several other medical conditions. However, persistent or unexplained symptoms should be evaluated by a qualified healthcare professional.

How Is Blood Cancer Diagnosed?

Accurate diagnosis is essential for identifying the specific blood cancer and selecting an appropriate treatment strategy. Haemato-oncology specialists use a combination of laboratory investigations, pathology assessments and imaging studies depending on the suspected condition.

Complete Blood Count (CBC)

A complete blood count measures red blood cells, white blood cells, haemoglobin and platelets. Abnormal results may indicate a blood-related problem and help determine whether additional investigations are required.

Peripheral Blood Smear

A peripheral blood smear involves examining a blood sample under a microscope to assess the size, shape and appearance of blood cells. It can provide useful information when certain blood cancers or blood disorders are suspected.

Bone Marrow Aspiration and Biopsy

Bone marrow aspiration and biopsy are specialised procedures used to examine blood-forming tissue. They can help identify abnormal cells, assess marrow function and classify certain blood cancers.

Flow Cytometry

Flow cytometry examines specific proteins and markers on cells. It is particularly useful in identifying and classifying certain types of leukaemia and lymphoma.

Cytogenetic and Molecular Testing

These investigations identify chromosomal abnormalities, genetic changes and molecular markers associated with particular blood cancers. The results can help classify the disease, assess risk and guide treatment decisions.

Imaging and Lymph Node Biopsy

Depending on the suspected cancer, doctors may recommend CT scans, PET-CT scans, ultrasound examinations or lymph node biopsies. These investigations help assess the extent of disease and support diagnosis and staging.

Haemato-Oncology Treatment Options

Blood cancer treatment is highly individualised. The recommended approach depends on the exact cancer subtype, disease stage, genetic findings, previous treatments and the patient's general health.

Modern haemato-oncology includes several treatment approaches, which may be used individually or in combination.

Chemotherapy

Chemotherapy uses medicines to destroy cancer cells or prevent them from multiplying. It remains an important treatment option for several types of leukaemia, lymphoma and multiple myeloma.

Treatment may be administered intravenously, orally or through other prescribed routes. The treatment schedule and duration depend on the cancer type and response to therapy.

Targeted Therapy

Targeted therapy uses medicines designed to act on specific proteins, genes or molecular pathways involved in cancer growth.

These treatments may be recommended when diagnostic testing identifies particular molecular or genetic features that make the cancer suitable for a targeted approach.

Immunotherapy

Immunotherapy helps the body's immune system recognise and attack cancer cells. Certain forms of immunotherapy are used for selected blood cancers, including specific lymphoma and leukaemia subtypes.

The suitability of immunotherapy depends on the disease characteristics and the patient's clinical condition.

CAR T-Cell Therapy

CAR T-cell therapy is an advanced form of cellular immunotherapy used for selected blood cancers. It involves collecting a patient's T cells, modifying them to recognise particular cancer targets and administering the modified cells back to the patient.

It may be considered for certain patients with specific types of leukaemia or lymphoma, depending on eligibility criteria, previous treatment and clinical indications. It requires specialist assessment and careful monitoring because it can cause significant treatment-related complications.

Bone Marrow and Stem Cell Transplantation

Bone marrow transplant (BMT), also known as haematopoietic stem cell transplantation, is a specialised treatment that replaces damaged or diseased blood-forming cells with healthy stem cells.

There are two major types:

• Autologous stem cell transplant: Uses the patient's own previously collected stem cells.
• Allogeneic stem cell transplant: Uses stem cells obtained from a suitable donor.

Transplantation may be considered for selected patients with leukaemia, lymphoma, multiple myeloma and certain other bone marrow disorders. The decision depends on disease type, treatment response, donor availability, organ function and overall fitness.

Radiation Therapy

Radiation therapy uses controlled doses of radiation to destroy cancer cells in specific areas of the body. It may be used in selected lymphoma cases, for localised disease management or to relieve symptoms caused by particular cancer-related complications.

What Happens During Haemato-Oncology Treatment?

Blood cancer treatment generally follows a structured clinical pathway, although the exact process differs between patients.

Initial consultation: The specialist reviews symptoms, medical history, previous treatment and available diagnostic reports.

Diagnostic confirmation: Additional blood tests, bone marrow investigations, biopsies or molecular studies may be recommended to establish the exact diagnosis.

Disease classification and risk assessment: Doctors evaluate the cancer subtype, disease characteristics, extent of involvement and other factors that influence treatment planning.

Treatment planning: The specialist discusses suitable treatment options, potential benefits, risks, alternatives and expected monitoring requirements.

Treatment and monitoring: The patient receives the recommended treatment with regular assessments to evaluate response and manage side effects.

Follow-up care: Continued monitoring helps assess disease status, identify complications and guide further medical management.

For complex conditions, a multidisciplinary team may include haemato-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, transplant specialists and supportive-care professionals.

Side Effects and Supportive Care During Blood Cancer Treatment

Blood cancer treatment can affect healthy cells and normal body functions. The type and severity of side effects vary depending on the treatment, dosage, individual health and underlying disease.

Possible treatment-related effects include:

• Fatigue and weakness.
• Nausea and vomiting.
• Hair loss with certain chemotherapy regimens.
• Increased risk of infections.
• Reduced blood cell counts.
• Mouth sores and changes in appetite.
• Bleeding or bruising due to low platelet levels.
• Nerve-related symptoms with certain medicines.

Supportive care is an important part of haemato-oncology management. It may involve infection prevention, nutritional guidance, blood or platelet transfusions, symptom control, psychological support and rehabilitation.

Patients receiving treatment should contact their medical team promptly if they develop fever, unusual bleeding, breathing difficulties or other symptoms identified by their treating clinician as requiring urgent attention.

Why Choose a Specialist for Blood Cancer Treatment?

Blood cancers are a diverse group of diseases, and two patients with the same broad diagnosis may require different treatment approaches.

Consulting a qualified haemato-oncologist helps patients receive an assessment focused on the specific cancer type, diagnostic findings and individual treatment needs.

When exploring hospitals and specialists, patients should consider:

• Relevant specialist qualifications and experience.
• Experience managing the specific blood cancer subtype.
• Availability of diagnostic pathology and molecular testing.
• Access to chemotherapy and specialised medicines.
• Bone marrow and stem cell transplantation facilities, where clinically relevant.
• Infection management and supportive-care facilities.
• Multidisciplinary treatment planning.
• Follow-up arrangements and continuity of care.

Patients should confirm the availability of each service directly with the relevant hospital because treatment facilities and specialist services can differ between locations.

Haemato-Oncology Treatment in India

India is an important destination for patients exploring specialised cancer diagnosis and treatment. Depending on the hospital and clinical requirements, patients may have access to medical oncology, haematology, specialised blood cancer investigations, chemotherapy, immunotherapy and stem cell transplantation.

For patients travelling from other cities or countries, selecting an appropriate healthcare provider involves more than comparing treatment prices. The specialist's experience, diagnostic facilities, treatment requirements, expected hospital stay and follow-up arrangements should all be considered.

Siris Healthcare helps patients explore hospital profiles, specialist information and available healthcare services across India. Patients and families can use the platform to identify relevant providers and enquire about treatment coordination.

Explore our Oncology Services, Medical Oncology Care and Haematology Services to understand related areas of cancer and blood disorder management.

How Siris Healthcare Helps Patients Explore Haemato-Oncology Care

A blood cancer diagnosis can involve several medical appointments, investigations and treatment decisions. Finding the right specialist and understanding the available care options can make this process easier to navigate.

Through Siris Healthcare, patients can:

• Explore relevant hospital profiles and medical specialties.
• Review available doctor profiles and their qualifications.
• Submit enquiries about blood cancer treatment.
• Explore specialist consultation options.
• Seek information about treatment planning and medical opinions.
• Understand practical arrangements for patients travelling to India.

Patients can begin by exploring our Hospital Directory and Doctor Directory to identify healthcare providers and specialists for further evaluation.

For patients who prefer an initial discussion, our Online Doctor Consultation service provides an additional way to explore consultation options, subject to doctor availability.

International patients can also review our Hospital and Doctor Guide, Medical Treatment Journey and International Patient Support before planning their healthcare arrangements.

Frequently Asked Questions About Haemato-Oncology

What is haemato-oncology?

Haemato-oncology is a medical specialty focused on diagnosing and treating cancers affecting the blood, bone marrow and lymphatic system. It primarily includes leukaemia, lymphoma, multiple myeloma and related malignant conditions.

Which doctor treats blood cancer?

A haemato-oncologist or a haematologist with specialist expertise in blood cancers generally manages these conditions. Depending on the diagnosis, medical oncologists, radiation oncologists and transplant specialists may also participate in treatment.

What are the most common types of blood cancer?

The major categories include leukaemia, lymphoma and multiple myeloma. Each category contains several subtypes with different clinical characteristics and treatment requirements.

Can blood cancer be treated with chemotherapy?

Yes. Chemotherapy is an important treatment for several blood cancers. However, treatment may also involve targeted therapy, immunotherapy, radiation therapy, CAR T-cell therapy or stem cell transplantation, depending on the diagnosis.

Is a bone marrow transplant necessary for every blood cancer patient?

No. Bone marrow or stem cell transplantation is recommended only for selected patients. The decision depends on the cancer type, disease risk, treatment response, donor availability and the patient's overall medical condition.

What tests are required to diagnose blood cancer?

Depending on the suspected condition, investigations may include a complete blood count, peripheral blood smear, bone marrow aspiration and biopsy, flow cytometry, molecular testing, lymph node biopsy and imaging studies.

Is blood cancer hereditary?

Most blood cancers are not directly inherited. However, certain inherited genetic factors may increase the risk of developing particular blood cancers. Individual risk should be discussed with a qualified medical professional.

How long does blood cancer treatment take?

Treatment duration varies considerably. Some patients require treatment over several months, while others need longer-term therapy and monitoring. The timeline depends on the specific cancer, treatment protocol, response and overall health.

Can patients travel to India for blood cancer treatment?

International patients may explore blood cancer treatment options in India, subject to their medical condition and travel suitability. They should obtain advice from the treating clinician before making travel arrangements and confirm hospital services, treatment costs and follow-up requirements.

How can I find a haemato-oncologist in India?

Patients can explore specialist profiles, hospital information and consultation options through Siris Healthcare. The treating provider should confirm the specialist's current qualifications, experience and suitability for the patient's diagnosis.

Speak to a Healthcare Specialist About Blood Cancer Treatment

Understanding a blood cancer diagnosis and available treatment options is an important first step towards informed medical decisions. Whether you are exploring treatment for leukaemia, lymphoma, multiple myeloma or another blood cancer, specialist assessment can help clarify the next steps.

Explore relevant hospitals and medical specialists through Siris Healthcare, or submit an enquiry to discuss your healthcare requirements.

Medical Disclaimer: This information is intended for general educational purposes only. It does not replace a medical consultation, diagnosis or treatment recommendation. Blood cancer diagnosis and treatment must be determined by qualified healthcare professionals based on individual clinical findings.